Category: Covid-19

Page 322«..1020..321322323324..330340..»

COVID-19 is not over: Local hospitals seeing an increase in cases – Williamsport Sun-Gazette

May 26, 2022

With the recent increase in COVID-19 cases, UPMC is continuing to limit access to its health care facilities to patients, identified and approved support persons, staff and essential vendors.

Dr. Rutul Dalal, medical director, Infectious Diseases, UPMC in North Central Pa., noted 189 patients were being treated for COVID across the health system, including 14 at area UPMC hospitals, which includes those in Williamsport, Muncy, Wellsboro and Coudersport.

Many other people are being tested and treated at home and not requiring hospital services.

However, we are seeing the increase in cases within the hospitals recently similar to trends from across the commonwealth and nation, he said. Our current volumes are much lower than what we experienced in the winter.

Dulal stressed the importance of people knowing the risks of infection and taking steps to protect themselves such as getting vaccinated, staying away from large, indoor crowds and masking, especially in big gatherings of people.

Vaccinations and boosters remain one of the best ways to continue to fight the spread of infection, he noted.

We also continue to require people who come to any UPMC facility to wear a face mask that covers their nose and mouth and to practice other prevention efforts like physical distancing, even if they are fully vaccinated, Dalal said.

Barbara Hemmendinger, of the Lycoming County Health Improvement Coalition and Lets End COVID, said now is not the time for people to let down their guards.

Much of the state, including Lycoming County, falls under the Centers for Disease Control and Infections high community level for COVID.

We are dealing with Omicron variants which are the most contagious we have ever seen, she said.

The caveat to that, she said, is that symptoms for many appear to be more mild than with other variants. However, many people can still develop symptoms which persist.

The CDC is recommending wearing masks indoors, she said. It is a recommendation and it is based on science.

She stressed the need for people to protect themselves and others against infection.

Today's breaking news and more in your inbox

Original post:

COVID-19 is not over: Local hospitals seeing an increase in cases - Williamsport Sun-Gazette

A preventative COVID-19 drug has opened up life for some immunocompromised Texans. But it remains unknown to many others – Houston Public Media

May 26, 2022

Jose Lazaro, a medical assistant at a University of Washington Medicine clinic, prepares a two-shot dose of AstraZenecas Evusheld, the first set of antibodies grown in a lab to prevent COVID-19, on Jan. 20, 2022, in Seattle.

During the first two years of the pandemic, Jennifer Pate asked herself one question before doing just about anything: is it worth dying over?'

She has two immune deficiencies that make her body unable to produce antibodies after an infection and fight viruses like COVID-19. The stakes of even the smallest daily tasks were life or death.

"Hey, do you think I could just, like, run in to HEB?'" Pate would ask her brother, a former executive of a major hospital.

"David will say, is it worth dying over?' And Ill say no.' Well, what about if I just ran into Target'. Is it worth dying over?' No.'"

Because of her conditions, Pate's doctors told her when the outbreak first reached Houston that the pandemic was likely a death sentence. She upended her life in an effort to protect herself any way she could: She started working from home. She relied on Amazon, Instacart and Doordash to avoid a trip to the grocery store. She would only go in public for the absolute essentials picking up medications and taking her pets to the veterinarian.

But news of a game-changing COVID-19 drug eventually helped Pate take those first steps outside her front door.

Evusheld, a preventative therapeutic that came on the scene in December, is a combination of monoclonal antibodies intended for immunocompromised people who don't mount an adequate immune response from vaccines such as cancer patients on chemotherapy or people with autoimmune diseases. Doctors can decide whether patients with chronic conditions like diabetes or liver diseases might benefit as well.

When Jennifer Pate found out, she told her doctor.

"Im getting it the nanosecond it comes out." Pate said at the time.

She was the first patient at Houston Methodist hospital to receive Evusheld in January. Shes still very careful, but has opened up her life in small ways. She feels comfortable letting in the plumber to fix the toilet, and she accompanied her mom to the ER after she broke her arm. Her risk tolerance has risen slightly.

"I'm not exaggerating, this was the most amazing day of my life," Pate said.

The injections, which are now under FDA emergency use authorization, are to be taken before an infection occurs. And the drug has been shown to be safe, said Dr. William Musick, a pharmacist at Houston Methodist Hospital.

Out of 20,000 patients, there were a couple of infusion reactions that required some additional monitoring and maybe some Benadryl and Tylenol, but other than that, it's extremely well tolerated, Musick said.

But this lifeline, which has calmed the anxieties of some immunocompromised, is going largely unnoticed.

Over the past six months, only a small number of Texans have taken advantage of the benefits. The Department of State Health Services has allocated 30,000 regimens to the whole state from December to early May, according to an email from a spokesperson. Much of that product is still sitting on the shelf.

Even though Texas was given 100,000 regimens from the federal government, low demand has stopped the state from allocating it to providers.

Sheri Innerarity, the chair of the Texas Nurse Practitioners Education Committee and a professor at UT Austin, says most people have never heard of Evusheld including healthcare professionals. She first found out about it in late March.

"There are no ads running on television," said Innerarity. "So if I didnt know about it and Im where I am, and I teach what I teach, I was pretty horrified about how many people would really not know about it."

"I had a patient who I really believed could have survived if he had known about this drug before he got COVID," Innerarity said.

A big reason people don't know is because drugmaker AstraZeneca is not marketing Evusheld. Thats because it doesnt have full formal approval through the FDA, according to Mark Esser, AstraZeneca's vice president of early vaccines and early therapies.

Thats one of the agreements under emergency use authorization, Esser said. Im sure youve seen pharmaceutical company ads on TV. We can do awareness, but were not doing direct-to-consumer. Maybe thats one reason folks arent so familiar with it.

The state health department has made efforts to inform providers, but not the general public. Local health departments in Houston and Harris County also haven't promoted Evusheld.

Innerarity said there are access issues for those who are aware of the therapeutic. In Harris County, there are only 10 locations, mostly concentrated on the west side. For rural areas, especially in parts of West Texas, the closest provider could be hundreds of miles away.

"Its absolutely an equity issue," Innerarity said. "If you dont have initial access and a provider who is aware, then it's not going to happen."

Stephanie Duke, an attorney at Disability Rights Texas, is not surprised that Evusheld remains relatively obscure. From testing to vaccines, there often isn't planning that includes the disabled community, she said.

"Unfortunately, I cant say Im shocked that nobody knows," Duke said. "But this is just kind of a general theme, right? Because during any disaster, people aren't aware."

For now, the treatment itself is free, although there could be administration fees charged by the provider. Duke wonders how long that will last as pandemic fatigue deepens and the federal government disinvests in COVID-19 funding.

Moving forward, she hopes to see all levels of government dedicate more resources to get the word out.

"There should be a targeted, coordinated response, somehow facilitated with state agencies, whoever, to push this word out, Duke said.

Fill out the form below to subscribe our new daily editorial newsletter from the HPM Newsroom.

See the original post:

A preventative COVID-19 drug has opened up life for some immunocompromised Texans. But it remains unknown to many others - Houston Public Media

COVID-19 likely to make health insurance more expensive for many in Maryland – Baltimore Sun

May 26, 2022

People who buy their own health insurance in Maryland may find again that they must pay more next year, likely due to costs from the coronavirus pandemic.

The three carriers offering policies on Marylands health exchange or directly to consumers under the Affordable Care Act requested rate increases from state insurance regulators averaging 11%.

It is clear from our ongoing monitoring of industry experience that 2021 claims were heavily influenced by COVID-19, and that the significant differences between where we were in 2021 and where we are likely to be in 2023 must be modeled and taken into account in rate development, said Kathleen Birrane, the states insurance commissioner, in a statement.

The Maryland Insurance Administration will review the requests and set rates in September for the insurance, also known as Obamacare.

More than 222,000 individuals bought coverage on the Maryland exchange or through the insurers this year, with close to 80% tapping subsidies to help pay premiums. Most are not offered insurance by their employers.

Tens of thousands of Marylanders gained insurance during special enrollment periods for those who lost insurance during the pandemic. More people were added during the pandemic to the rolls of Medicaid, the federal-state health program for low-income residents.

Some now risk being removed from Medicaid as officials resume checking whether participants remain qualified, a practice that was suspended during the pandemic health emergency.

Federal subsidies added to private plans during the pandemic also will expire by the end of the year if Congress does not renew them, though most people will retain aid to buy their plans.

There are about 1.2 million Marylanders enrolled in income-based Medicaid plans and about 175,000 enrolled in private plans.

State regulators say they will take pandemic-related changes to costs and enrollment into account when they approve rates, along with the actual impact of the coronavirus on costs.

Obtaining more detailed information on how COVID-19 claims experience has influenced cost and trend models for 2023 will be the primary focus for our actuarial team, Birrane said.

CareFirst BlueCross BlueShield, the states dominant carrier, asked for an average 11.2% rate increase in its HMO plan, which covers more than 149,000 people. That would mean an extra $30 a month for a policy holder with an average-priced silver plan, pushing it up to $353.

CareFirst requested a 25.9% rate increase for its PPO plan, which covers nearly 16,300 people.

United Healthcare is seeking an average 8.7% increase for its HMO plan. The monthly cost for a policy holder with a silver plan would rise by $28 to $363.

Daily

Get your morning news in your e-mail inbox. Get all the top news and sports from the baltimoresun.com.

Kaiser Permanente asked for an average 7.2% for its HMO plan, which covers almost 64,900 people. That would raise the premium for a policy holder with a silver plan by $14 to $275 a month.

Kaiser Permanentes proposed 2023 individual and family plan rates reflect the anticipated costs of providing high-quality health care and coverage for all our members over the long term, Kaiser said in a statement. We believe consumers will find us to be a competitive and comprehensive choice when they seek health coverage for 2023.

Providers of health insurance for small businesses also requested an average 10% increase.

For the current year, state regulators ended up approving premium hikes for individuals averaging about 2.1% for the nearly three dozen plans offered by the three insurance companies on the exchange.

That followed several years of major reductions in costs due to a reinsurance program passed by the General Assembly that helped offset the bills for insurers from the costliest beneficiaries. It replaced a program killed by Republicans in the U.S. Congress.

The Maryland Insurance Administration expects to hold public hearings on the rate requests in July.

CareFirst and United Healthcare didnt respond Wednesday to requests for comment.

Continue reading here:

COVID-19 likely to make health insurance more expensive for many in Maryland - Baltimore Sun

Leukemia After COVID-19: Is There a Connection? – Healthline

May 26, 2022

More than 500 million people have been diagnosed with COVID-19 since late 2019. Most people who develop COVID-19 have mild disease, but theres compelling evidence that people with certain health conditions like leukemia are at elevated risk of severe disease or death.

A 2021 study presented at the 63rd American Society of Hematology Annual Meeting and Exposition found that people with blood cancer have a 17 percent chance of dying from COVID-19, significantly higher than the general population.

Its less clear if COVID-19 increases your risk of developing leukemia or other blood cancers. Some researchers think its plausible that COVID-19, in combination with other factors, could contribute to cancer development. At this time, the link remains theoretical.

Read on to learn more about how COVID-19 could, in theory, contribute to the development of leukemia.

Some types of blood cancer have been linked to infections. Its not clear if COVID-19 contributes to the development of leukemia, but scientists have found some theoretical links.

Cancer development is usually a consequence of multiple factors that drive genetic mutations in cancer cells. Its plausible that COVID-19 could predispose your body to cancer or accelerate cancer progression.

Most people with COVID-19 recover within 2 to 6 weeks, but some people have symptoms that linger for months. Its thought that the lingering effects result from chronic low grade inflammation triggered by the SARS-CoV-2 virus that causes COVID-19.

Chronic inflammation can cause DNA damage that contributes to the development of cancer. In a study published in April 2021, researchers hypothesized lingering inflammation in people with COVID-19 could increase cancer risk.

The immune response in people with COVID-19 is orchestrated by pro-inflammatory molecules linked to the development of tumors, specifically:

COVID-19 is also associated with other processes known to drive cancer formation such as:

A few case studies have reported people admitted to the hospital with leukemia shortly after developing COVID-19. However, its not clear if COVID-19 played a role or how much of a role it played. Leukemia may have developed coincidentally.

The authors of a 2022 study present a theoretical framework of how COVID-19 could influence the development of blood cancers. According to the researchers, an abnormal immune response to viral infections can indirectly trigger gene mutations that promote leukemia.

The virus that causes COVID-19 can also significantly interact with the renin-angiotensin system, which is suggested to have a role in the development of cancerous blood cells.

In a case study published in 2021, researchers present the case of a 61-year-old man who developed acute myeloid leukemia 40 days after developing COVID-19. The researchers concluded that more studies are needed to assess whether theres an association between COVID-19 and acute leukemia.

In another case study from 2020, researchers presented a man who developed COVID-19 as the first sign of chronic lymphocytic leukemia (CLL). The researchers found that the persons lymphocyte count doubled over 4 weeks, suggesting the viral infection is associated with the replication of B cells, the type of white blood cell that CLL develops in.

Some other types of viral infections have been linked to the development of leukemia.

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and its rates have been increasing. Growing evidence strongly suggests an abnormal immune response to infections early in life is responsible.

Having a human adult T-cell leukemia virus type 1 infection is linked to the development of T-cell leukemia. This virus is transmitted primarily through bodily fluids. The World Health Organization estimates that 5 to 10 million people have the viral infection.

Some types of infections have been linked to the development of another type of blood cancer called lymphoma. They include:

The FDA has approved the drug remdesivir for adults and some children with COVID-19.

At the time of writing, theres no evidence that remdesivir can cause leukemia.

In a 2021 study, a 6-year-old child with newly diagnosed ALL and COVID-19 was treated with remdesivir and convalescent plasma therapy before starting leukemia treatment.

No adverse events were linked to the therapy, and the researchers concluded this treatment could be considered in people with cancer to accelerate the resolution of the viral infection and to start cancer treatment sooner.

Some researchers have raised concerns that the antiviral drug molnupiravir, which received FDA Emergency Use Authorization on December 23, 2021, could potentially cause cancerous mutations or birth defects. Researchers are continuing to examine these potential adverse effects.

The development of blood cancer is complex. Researchers are continuing to examine whether COVID-19 infection can contribute to the development of leukemia or any other blood cancer. Some researchers have posed a theoretical link, but more research is needed.

None of the vaccines approved for use in the United States interact with your DNA or cause cancer, according to the Centers for Disease Control and Prevention (CDC). Its a myth that mRNA vaccines (Pfizer-BioNTech and Moderna) can cause changes to your DNA.

About 25 percent of blood cancer patients dont produce detectable antibodies after vaccination, according to the Leukemia & Lymphoma Society (LLS). However, the CDC continues to recommend that everyone with cancer still get vaccinated.

LLS experts say vaccination should be combined with other prevention precautions for the best protection.

People with cancer seem to be at a higher risk of severe COVID-19. According to the National Cancer Institute, people with blood cancer may have a higher risk of prolonged infection and death than people with solid tumors.

Researchers are continuing to examine the link between leukemia and COVID-19. Strong evidence suggests that people with leukemia are at an increased risk of developing severe COVID-19.

Some researchers have posed that COVID-19 could contribute to leukemia formation, but as of now, the link remains theoretical. Much more research is needed to understand the connection.

View post:

Leukemia After COVID-19: Is There a Connection? - Healthline

Global excess deaths associated with COVID-19, January 2020 – December 2021 – World Health Organization

May 26, 2022

The global excess mortality associated with COVID-19 was 14.91 million in the 24 months between 1 January 2020 and 31 December 2021, representing 9.49 million more deaths than those globally reported as directly attributable to COVID-19.

The impact of the pandemic has been over several waves with each characterized by unique regional distributions, mortality levels and drivers. Twenty countries, representing approximately 50% of the global population, account for over 80% of the estimatedglobal excess mortality for the January 2020 to December 2021 period. These countries are Brazil, Colombia, Egypt, Germany, India, Indonesia, the Islamic Republic of Iran, Italy, Mexico, Nigeria, Pakistan, Peru, the Philippines, Poland, the Russian Federation, South Africa, the United Kingdom of Great Britain and Northern Ireland, Turkey, Ukraine, and the United States of America (USA). We are able to observe the evolution of the pandemic over these 24 months as different regions and countries were impactedby and responded to the threat of COVID-19.

See more here:

Global excess deaths associated with COVID-19, January 2020 - December 2021 - World Health Organization

Lessons from the front lines of the COVID-19 crisis – Smartbrief

May 24, 2022

Providence Regional Medical Center in Everett, Wash., identified the United States first known COVID-19 patient on January 20, 2020, marking the onset of a health care crisis whose proportions would have been difficult to imagine at the time. Soon afterward, the health system also took on a pioneering role in treating COVID-19 patients with the antiviral drug remdesivir.

As of April 2022, the US has counted 81 million cases of coronavirus infection and almost 1 million deaths nearly a sixth of the worlds total lives lost to date and the pandemic has done no less than permanently alter the way health care organizations operate and practice medicine.

In a conversation with SmartBrief, Darren Redick, chief executive of the Providence Swedish North Puget Sound health system, offered some constructive hindsight on challenges the crisis has presented and solutions his organization found to address them.

SB: Looking back on the last two years, what has Providence learned about handling the high-stress and high-volume patient care demands of a pandemic? What processes and precautions did you already have in place before the COVID-19 crisis?

DR: As the hospital that admitted the first known COVID-19 patient in the United States, Providence Everett has been on the frontlines of the pandemic from the very beginning. We were uniquely prepared, however, and our Biocontainment, Evaluation, and Specialty Treatment (BEST) team had just run through a full drill two weeks prior to the first patient arriving, in which they practiced receiving and caring for an infectious disease patient. We have a special unit we can set up for infectious disease patients, and that unit was used for the first COVID patient. For years, we have done regular drills for that unit going back to when we were preparing for the possibility of an Ebola patient. Our drills include our community partners, such as the Health District, EMS, the Northwest Healthcare Response Network, and more. One reason the process for the initial patient went well is the drill we had a couple of weeks prior included our community partners.

We also have a medical tower that was designed with a pandemic in mind, so an entire floor has reverse air flow capabilities. These pandemic HVAC systems are available for 64 beds across two units. In addition, as part of the Providence health system, we had a relatively good supply of PPE available. These factors have been extremely helpful throughout the pandemic to help limit exposures in the hospital. The high-stress and high-volume demands of the pandemic have been extremely difficult, but our caregivers have endured with compassion and strength, and I am so proud of them and humbled to work with them. Our Providence mission calls for us to be steadfast in serving all, and our caregivers have indeed provided excellent care throughout the pandemic.

Also, for years we have had in place a Service Operations and Transfer Center to manage operations, and that has proven invaluable throughout the pandemic.

SB: When the next pandemic arrives, how will your staff and facilities be better prepared for it? Have you added equipment, permanent training programs, more treatment space, technology, other tools that can help?

DR: Health care has been fundamentally altered by the pandemic in many ways. For example, we quickly pivoted to provide many telehealth and virtual care options for our patients during the pandemic, and many of those programs will continue. This is a great option for many patients and also allows resources to be deployed to more critical patients. Specifically, at Providence Everett, we have developed many new training programs and protocols around infection prevention, care and treatment of infectious disease patients, and more. We also have the ability to quickly flex and adjust our operations based on the situation. All of these experiences, and many more, will be important as we face future COVID-19 surges, another pandemic, or other challenges.

From a building system standpoint, I think we have also been well prepared. We understand that health care is a larger, connected system and that impacts to any portion of the system (primary care, specialty care, ambulatory care, post-acute services, long term care services) all affect one another. As a community of health care services and organizations, it is clear we need to plan and work together to best manage the effects of pandemics and other critical community health issues.

SB: What is it like handling the psychological uncertainty and stress of a pandemic especially when you know more infectious diseases will appear, but you dont know how much differently they will present, or how severe they will be?

DR: The uncertainty and stress for all frontline health care workers has been intense, and Providence has implemented a multitude of programs and resources to help with mental health concerns, child care challenges, work-life balance, and much more. As a specific example, we have trained and deployed Critical Incident Stress Management teams to help caregivers after they have been through a difficult situation. These teams allow caregivers to debrief after an incident, share how theyre feeling, be connected to resources, and more. Our caregivers are here because they are passionate about caring for others. Health care is a calling, and that has never been more apparent than during the last two years.

SB: Were there any pandemic protocols or technologies that you thought would be effective in managing patient care, but that turned out to be less helpful? What did you learn from those situations?

DR: Throughout the pandemic we have followed guidance from the CDC and the Department of Health, which is based on evidence-based best practices. The entire world has seen science play out in real time throughout the pandemic, and weve all learned that the process is not always linear. However, by following proven treatments and established protocols, we have provided excellent care to our patients.

SB: What kinds of organizations have you partnered with to educate and prepare staff and the hospital for future outbreaks?

DR: Beginning with the very first COVID patient and even before that, during drills we worked closely with our local health department, EMS, fire department, and more. Throughout the pandemic, weve partnered with other hospitals in the state to level patient load so that no single hospital got overwhelmed during a surge. This helped keep Washington state from declaring crisis standards of care. This coordination of care among hospitals and health organizations throughout our state is extremely important and has positioned us well for future challenges.

SB: Have other hospitals approached you to advise them on establishing better pandemic protocols? If so, how do you handle those requests?

DR: Since we successfully treated the first COVID-19 patient in the US, weve been getting calls from other hospitals around the country for two years. Health care is all about sharing information and best practices to help advance patient outcomes. For example, in March 2020, our team published a case report of the first patient in the New England Journal of Medicine to help share our experience and how the patient was successfully treated with remdesivir. Throughout the pandemic, we have also worked closely with the Washington State Hospital Association to share information, and WSHA has done a tremendous job helping hospitals coordinate and respond.

SB: What have been the most rewarding and encouraging outcomes from your preparedness efforts? Can you share any data or study results on efficiencies, cost savings, patient health impact?

DR: The most rewarding and encouraging part is the stories of the patients who recover. For example, USA Today featured this story of a Providence Everett patient who spent 25 days on a ventilator, but made a full recovery and was reunited with her family. Knowing that the drills and the training, the protocols and procedures, the foresight to have a floor with reverse air flow, and most of all, the dedication, care, bravery and expertise of our caregivers, all played a role in saving so many lives is extremely powerful. Throughout the pandemic, we have also been at the forefront of research and new therapies.

We were the first in the world to administer remdesivir to a COVID-19 patient. We have published numerous studies about care and treatment of COVID-19, and shared a lot of information with the public to help educate them and promote best practices. Examples include this paper on Remdesivir and Mortality Rates in Patients with COVID, as well as this account on the role of technology in COVID-19 care and delivery.

More here:

Lessons from the front lines of the COVID-19 crisis - Smartbrief

Covid News: F.D.A. Sets Date for Panel Debate on Pfizer and Moderna Vaccines for Youngest Children – The New York Times

May 24, 2022

In late September of 2020, captive mink on a farm in Michigan suddenly fell ill. They stopped eating, struggled to breathe and bled from the nose, according to a report from the World Organization for Animal Health. Two thousand animals died.

Laboratory testing soon confirmed that the mink were infected with the coronavirus.

The Centers for Disease Control and Prevention dispatched a team of outbreak investigators, who collaborated with other agencies to swab mink, farm workers and a menagerie of other animals, from rats to raccoons, to determine how the virus had spread.

We tried to leave no stone unturned, said Dr. Casey Barton Behravesh, who directs the C.D.C.s One Health Office.

Last month, the C.D.C. confirmed that four Michigan residents, including two farm employees, had been infected with the same unique coronavirus variant that was found in the mink. It was the first, and so far only, known instance of possible animal-to-human transmission in the United States.

But many questions remain: When, and in whom, did the variant first emerge? How did a taxidermist with no connection to the farm contract it? Could there be a link between the Michigan mink outbreak and a white-tailed deer variant that scientists recently discovered in neighboring Ontario?

It really feels very much like a puzzle, said Dr. Samira Mubareka, a virologist at Sunnybrook Research Institute and the University of Toronto. Its not just pieces that are missing its contiguous, interlocking pieces that are missing.

Since the early days of the pandemic, when the coronavirus tore through fur farms, scientists have worried that mink might become a long-term reservoir for the virus and a potential source of new variants.

To date, coronavirus infections have been detected in mink on 18 American farms, the most recent in Wisconsin in February. Even as Congress considers a ban on mink farming, there is still no national system for proactive surveillance on mink farms, which are not required to report cases to federal authorities. And officials have not released much information about the outbreak investigations they have conducted; some of those details are reported here for the first time.

Together, the secrecy and spotty surveillance make it difficult to determine how much of a risk mink farms pose, scientists say. And it threatens to leave experts blind to the emergence of worrisome new variants that could spill back into humans, extending the pandemic.

Combined with a desperate need for better more systematic surveillance in humans and animals, we could really benefit from increased transparency regarding spillover and spillback risk, said Vivek Kapur, a veterinary microbiologist at Penn State University.

The Netherlands and Denmark were the first countries to report mink farm outbreaks, in the spring and summer of 2020. Scientists pieced together an unsettling chain of events: It appeared that humans had transmitted the virus to mink; that the virus had mutated as it moved among the mink, and that the animals then spread the altered virus back to humans.

All of that jumping back and forth over the fence is what we saw, said Dr. Marion Koopmans, a virologist at Erasmus University Medical Center in Rotterdam. And thats something that, as a virologist, you dont really like.

The Netherlands and Denmark took quick and decisive action, said Adriana Diaz, a doctoral student at the University of London who studied these responses. Dutch authorities conducted antibody testing on all farms and required farmers to report respiratory symptoms in mink and regularly submit carcasses for examination. Still, the virus proved difficult to control, and both nations ultimately shuttered their mink farms.

The United States took a different tack, developing a set of voluntary guidelines to help farmers keep the virus at bay, including asking farm workers to wear masks and notifying authorities of suspected cases.

But there was no national screening program and federal officials relied upon farm owners to self-report outbreaks. All of our federal surveillance efforts are voluntary, said Dr. Tracey Dutcher, the science and biodefense coordinator for the Animal and Plant Health Inspection Service at the United States Department of Agriculture.

The C.D.C. investigated outbreaks only when officially invited. Some owners of affected farms declined to participate, and field teams only performed on-site investigations on eight farms, Dr. Barton Behravesh said.

On the Michigan farm, C.D.C. investigators worked with the U.S.D.A. and state agencies to test humans and animals for the virus. They collected swabs and samples from 159 mink on the farm; all but two were actively infected, Dr. Barton Behravesh said.

None of the other animals tested around the farm two dogs, a cat, raccoons, opossums, striped skunks, rats, groundhogs and rabbits were infected, but one dog tested positive for antibodies, officials said.

Two of the farms employees were infected with the same version of the virus that was spreading among the mink. The variant had two mutations that had also been found in farmed mink in Europe and in people connected to mink farms.

Officials found the same mutations in a sample collected from another Michigan resident nearly two months after the mink outbreak and then in a fourth person connected to that resident. The third case was a local taxidermist, according to internal health department emails obtained by the Documenting Covid-19 Project and the Detroit Free Press, and the fourth case was the mans wife, the organizations later reported. (Michigans Department of Health & Human Services declined to confirm these details for privacy reasons.) Neither had any known connection to the mink farm.

These findings suggest a likely scenario, experts said: A person passed the virus to the mink, and the mutations emerged as the virus spread among the animals, which then transmitted them back to the farm workers. We concluded that there was likely mink-to-person spread on this particular Michigan farm, Dr. Barton Behravesh said.

But determining when, and in whom, the mutations first appeared requires many more virus samples from farm workers, local residents and mink, collected before and after the outbreak. That data doesnt exist, said Arinjay Banerjee, a virologist at the University of Saskatchewan.

Throughout 2020, testing was difficult for Americans to access and few patient samples were being sequenced. Surveillance in animals was even worse; until this spring, federal officials explicitly recommended against routinely testing animals for the virus.

Widespread testing wasnt available, then there became a shortage of certain supplies, Dr. Behravesh said. So we didnt want there to be, you know, a mad rush to test animals.

Without more samples, its impossible to rule out the possibility that the variant emerged in humans, who then spread it to mink, scientists said.

A bigger puzzle is how the taxidermist and his wife got it. The most likely possibility, several experts said, is that the variant was circulating more widely in the human population than was known, and the couple caught it from another infected person.

Another, more speculative, possibility is that they picked up the variant from another animal species. Taxidermists deal with other dead animals, said Linda Saif, a virologist and immunologist at Ohio State University.

But because the cases were detected weeks to months after the two fell ill, testing any animals they may have been in contact with was either not feasible or not indicated, said Lynn Sutfin, a spokesperson for the Michigan D.H.H.S.

The pair also had close contact with deer while hunting on or very near to their own illness onset dates, according to the health department emails obtained by the Documenting Covid-19 Project and the Free Press.

Studies suggest that humans have repeatedly introduced the virus to white-tailed deer, which then transmit it easily among themselves. People could have passed the mink variant to deer, which might have transmitted it to the taxidermist and his wife. Given the very high viral burdens that have been noted in white-tailed deer, the spillover to them could certainly have occurred from the deer, Dr. Kapur said.

Alternately, deer might have picked up the virus directly from infected mink, which have been known to escape from farms. Feral cats on mink farms have also tested positive for the virus and may act as vectors between captive mink and wildlife.

Or deer might come into contact with mink farm waste, Dr. Kapur said. On farms with outbreaks, airborne dust, as well as the straw and hay that the mink bed down on, can be highly contaminated with virus, Dutch researchers found.

Another finding makes a potential deer link intriguing, scientists said. Canadian researchers recently detected a unique coronavirus variant circulating in deer in southwestern Ontario. Although the deer variant was strikingly different from other known variants, the closest matches were viral samples collected from people and mink in Michigan in late 2020.

One possibility, still theoretical, is that whatever version of the virus was circulating among mink and humans made its way into deer, where it evolved into a new variant. There could be interactions and interspecies transmission that have been cryptic and we havent really picked up on , said Dr. Mubareka, an author of the Ontario study.

Dr. Banerjee was skeptical that deer played a role in the case of the taxidermist and his wife. I think thats just speculation at best, he said. But he acknowledged that the data are so sparse that many possibilities remain. Are there other animals we are missing? he asked.

Even the data that exist are not always clear-cut. As part of another investigation in the fall of 2020, the U.S.D.A. tested a dozen cattle on a Wisconsin mink farm with a coronavirus outbreak. Although the cattle tested negative for the virus, three had low levels of antibodies, said Travis Weger, a U.S.D.A. spokesperson.

However, these findings did not meet the criteria for a positive result, Mr. Weger said in an email, and could have been triggered by antibodies to other coronaviruses known to infect cattle. Experimental studies suggest that cattle are not susceptible to SARS-CoV-2, he added.

Still, outside experts said that it is difficult to draw conclusions without more analysis and that the findings suggest a need to monitor livestock, especially as new variants emerge.

Some also expressed concern that officials have not disclosed these and other findings from the mink investigations.

Dr. Barton Behravesh, of the C.D.C., said that the viral sequences obtained during the investigations are available on GISAID, a repository of viral genomes, and that more details would eventually be published in scientific journals.

The U.S.D.A. is using funding from the American Rescue Plan to ramp up animal surveillance and would like to do more active monitoring on mink farms, Dr. Dutcher said: Were still working through some of the questions and conversations with industry.

Although the U.S.D.A has no reports of active outbreaks after 2020, mink infections can be silent. Researchers found antibodies in mink on a Wisconsin farm in February 2022 and on a farm in another, unnamed state in May 2021. There was no evidence of symptomatic outbreaks on either farm, which had supplied samples from healthy animals for research, Mr. Weger said in an email.

But the presence of antibodies suggests that the virus spread on the farms undetected.

Without surveillance, how would you know? said Dr. Jim Keen, the director of veterinary sciences at the Center for a Humane Economy, a nonprofit animal welfare organization that supports banning mink farming in the United States.

Some mink herds have now been vaccinated, which might help slow transmission on farms. But vaccination could make infections more likely to be asymptomatic, Dr. Keen said.

The United States should be regularly testing both mink and farm employees, sequencing positive samples and communicating the results in a timely way, Ms. Diaz said.

As new variants emerge, some perhaps capable of infecting new species, ongoing surveillance is needed to understand the web of transmission that may be going on with wildlife, farmed animals and humans, Dr. Saif said. If you dont look for something, youre not going to find it.

Excerpt from:

Covid News: F.D.A. Sets Date for Panel Debate on Pfizer and Moderna Vaccines for Youngest Children - The New York Times

Advice in the time of COVID-19 – World Bank Group

May 24, 2022

A once-in-century challenge

The COVID-19 (coronavirus) pandemic has seen governments around the world grappling with unprecedented and uncharted challenges. Leaders across Africa, including in South Africa and Nigeria, sub-Saharan Africas largest economies, have needed to make major decisions to navigate a twin public health crisis and economic crisis throughout 2020 and 2021. Many of the choices they faced had no textbook. No one had been here before.

Those tasked with advising presidents faced a similarly daunting task. How do you provide the best possible advice in such conditions? Like the rest of the world, African governments had little precedence to rely on when formulating economic policy options. And the approaches being deployed in Asia and Europe might not be suitable for the specific conditions and constraints they faced at home. And how might the World Bank be able to help?

What was needed was a way of pooling their knowledge while drawing on outside expertise to quickly get insight into what we knew about the pandemic. To provide a place where these advisors could exchange with one another and get feedback on their approaches to the unique challenges that the pandemic was generating.

So, when chief economic advisors to the Presidents of South Africa and Nigeria, along with 40 other African countries, needed to pool knowledge and gain critical insights and feedback on their approaches to the pandemic and economic responses, they turned to the Chief Economists of Government (CEoG) network, an initiative of the Africa Office of the Chief Economist at the World Bank. This network comprises chief economic advisors to heads of the executive from more than 40 of the 48 Sub-Saharan African countries.

These chief economic advisors have met every few weeks throughout the pandemic since March 2020, via virtual meetings convened by the World Bank. These meetings have provided a safe space to discuss difficult questions and get peer feedback on the issues of the day they are grappling with.

CEoG: An African network to address Africas problems

The Chief Economists of Government initiative aims to promote economic growth and transformation by strengthening knowledge-based policymaking in African countries. It was initiated by the Africa Chief Economists Office, recognizing an absence of support and peer exchange for this special group of individuals; those tasked with advising the President or Prime Minister on critical economic matters.

Not knowing the COVID-19 pandemic was just around the corner, the network was launched in February 2019 with an inaugural event at Oxford University bringing together the network of African chief economic advisors, and connecting them to those who had played this role in the past, both in Africa and from countries such as Malaysia.

Then COVID-19 struck. However, a crisis often comes with an opportunity: as the first African governments started implementing COVID-19 response measures, CEoG started hosting regular peer-learning webinars, offering advisors a space to share their countries pandemic response measures and economic recovery plans, discuss and receive feedback on investment incentives or climate mitigation and adaptation strategies, and get together to discuss, formulate and agree on specific inputs to the Abidjan Declaration, calling for IDA donors to support an ambitious IDA20 replenishment with success! Transparency, trust and flexibility has allowed this demand-driven network to be owned by its members, choosing the topics and requests for outside experts.

CEoG members straddle economies totaling almost two trillion US dollars with the typical economy almost as large as $40 billion and per capita income of almost $2,500. The goal is to have the CEoG network facilitate more rapid economic growth and transformation of its member countries.

Throughout the pandemic and going forward, the CEoG Secretariat continue to organize demand-driven thematic workshops and virtual peer-learning events for the advisors. The advisors will also identify specific challenges where additional support may be useful. For instance, when our network member from the Democratic Republic of Congo (DRC) was tasked with formulating a plan to reduce the dollarization of the economy in DRC, they turned to the CEoG network to help convene other advisors and experts to help share insights that could inform the countrys de-dollarization efforts.

The future

The network now regularly brings together the chief economic advisors from each of almost every country in the Sub-Saharan Africa region. This year the network is launching the CEoG Presidential Fellowship program, to give the most talented African economists the opportunity to work in the highest levels of government across the region.

To support future chief economic advisors, the network is also documenting the experiences of current and former advisors to President, to form a guide to the experiences associated with this unique and challenging job.

We invite you learn more about the CEoG network.

See original here:

Advice in the time of COVID-19 - World Bank Group

Why the Gym is Risky for COVID-19, and Tips for Keeping Safe – TIME

May 24, 2022

COVID-19 has been frustrating for gym rats. Even before scientists knew much about this particular virus, it was pretty clear that breathing heavily in a confined space with lots of other people around doing the same was an easy way to catch a respiratory illness, and gyms were among the first businesses to close early in the pandemic. These suspicions have since been borne out by science: aerosolstiny droplets that spread through the air when we breathehave been identified as a major source of COVID-19 transmission, especially when people are breathing faster and more deeply. Throughout the pandemic, exercise at spin classes, fitness clubs and sports games has been identified as the source of dozens of new cases.

Now a new experiment has given us a more exact sense of just how many aerosols a single person can spew during an intense workoutand the results arent pretty. According to research by scientists in Germany published in PNAS on May 23, people emit about 132 times as many aerosols per minute during high intensity exercise than when theyre at rest, which the researchers warn raises the risk of a person infected with COVID-19 setting off a superspreader event. At rest, people emitted an average of 580 particles each minute, but during maximal exercisein which researchers gradually increased intensity until the subjects were exhaustedpeople emitted an average of 76,200 particles a minute.

The study authors acknowledge that their work has limitations. First and foremost, the sample size was just 16 people. In addition, none of the subjects were infected by COVID-19; in the paper, the researchers note there was no way to do so safely, due to ethical concerns about the health risks for participants.

Nevertheless, there were some valuable findings to come out of the work. [As an exercise physiologist], and we knew before that when you exercise, theres more air coming out of a person, says Henning Wackerhage, a co-author and professor of exercise biology at Technische Universitt Mnchen. But we didnt know before, and which, quite frankly, I didnt expect, is that also when we exercise hard: there are more particles per liter of air.

The unusual experiment design enabled the researchers to get a more exact sense of the particles released. While exercising on a stationary bike, each of the 16 subjects breathed clean air through a silicone face mask, and then exhaled into a plastic bag. This enabled the researchers to eliminate sources of contamination and get more reliable results, says Christian Khler, a professor at the Institute of Fluid Mechanics and Aerodynamics at Universitt der Bundeswehr Mnchen who co-authored the study.

Some of the participants also emitted much more aerosols during high-intensity exercise than others; in particular, fitter people with more experience in endurance training emitted 85% more aerosols than people without such training. Dr. Michael Klompas, a hospital epidemiologist and infectious disease physician at Brigham and Womens Hospital who did not participate in the study, explains that this may be a function of the way individuals bodies become more efficient at moving large amounts of air. They make their muscles do an enormous amount of work, and they need to support that by giving their muscles enormous amounts of oxygen and helping to clear waste products, he says.

If this gives you pause about your current exercise regimen, keep in mind that not all gyms are alikeand the right policies and set-up can help to keep you safe. For instance, the amount of space per person is essential; large spaces, especially those with high ceilings, give the air more space, says Thomas Allison, director of Cardiopulmonary Exercise Testing Laboratories at the Mayo Clinic. Other things to look for at a gym, says Klompas, are a vaccination requirement, a facility that has professionally measured the air flow and put in place air filters, and, ideally, a testing requirement. In Klompas opinion, masks are potentially helpful, but arent likely to be reliable during workoutslooser masks wont do much during vigorous exercise, and its impractical to expect people to wear N95s while exerting themselves.

The researchers note that factors besides fitness status can also affect how many aerosols people emit. Wackerhage says they are also looking into how factors like body mass index, age, and lung condition play a role.

Ultimately, says Klompas, whether or not you go to a gym comes down to your risk tolerance, and weighing the costs and benefits of going to the gym for you, personally. However, he says, you shouldnt pretend that working out indoors, and around other people, doesnt pose risks. If youre not willing to get COVID dont go, says Klompas. At a time like now, when theres a lot of COVID around, it is a high risk proposition.

More Must-Read Stories From TIME

Contact us at letters@time.com.

Link:

Why the Gym is Risky for COVID-19, and Tips for Keeping Safe - TIME

COVID-19 deaths to increase in next month: 3 forecasts to know – Becker’s Hospital Review

May 24, 2022

COVID-19 deaths are decreasing nationwide in the wake of this winter's omicron surge, but CDC modeling suggests this trend may change over the next four weeks.

Three COVID-19 forecasts to know:

Cases: Daily COVID-19 cases are projected to increase 92.2 percent in the next two weeks, according to modeling from Mayo Clinic. Forecasts suggest daily average cases will jump from 93,401 cases on May 21 to 179,547 by June 4. During the omicron surge, this figure hit a peak of more than 800,000, according to data tracked by The New York Times.

The nation's case rate is also expected to increase from 33.3 cases per 100,000 population to 54.7 per 100,000 over the same period.

Hospitalizations: Nationwide, daily COVID-19 hospital admissions are projected to increase over the next four weeks, with 1,300 to 11,000 new admissions likely reported June 10, according to the CDC's ensemble forecast from 18 modeling groups.

Hospitalizations are increasing, but the nation's current seven-day average (3,250) is still far lower than the more than 20,000 new admissions seen at the height of the omicron surge, according to data tracked by the Times.

Deaths: U.S. COVID-19 deaths are also expected to increase over the next month, according to the CDC's ensemble forecast from 22 modeling groups. The forecast projects 2,000 to 5,300 deaths likely reported in the week ending June 11, which would bring the nation's total COVID-19 death tally to a range of 1,008,000 to 1,018,000.

The CDC said its ensemble forecasts are among the most reliable for COVID-19 modeling, but they cannot predict rapid changes in cases, hospitalizations or deaths. Therefore, they should not be relied on "for making decisions about the possibility or timing of rapid changes in trends," the agency said.

Note: Mayo Clinic uses a Bayesian statistical model to forecast cases that automatically updates as new data becomes available. There is an uncertainty interval for forecast values, with lower and upper bounds that are not included in this list. To learn more about the data Mayo Clinic uses to forecast hot spots, click here. Becker's pulled the forecast values May 23 at 9:10 a.m. CDT.

Read the original post:

COVID-19 deaths to increase in next month: 3 forecasts to know - Becker's Hospital Review

Page 322«..1020..321322323324..330340..»